These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28283268)

  • 1. Perioperative management of vitamin K antagonists in patients with low thromboembolic risk undergoing elective surgery: A prospective experience.
    Becerra AF; Cornavaca MT; Revigliono JI; Contreras A; Albertini R; Tabares AH
    Med Clin (Barc); 2017 Oct; 149(7):281-286. PubMed ID: 28283268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perioperative control of vitamin K antagonists in elective surgery].
    Revigliono JI; Cornavaca T; Becerra F; Albertini R; Contreras AE; Tabares A
    Medicina (B Aires); 2014; 74(5):385-90. PubMed ID: 25347900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging anticoagulation in patients treated with vitamin K antagonists prior to trochanteric and hip fracture surgeries: The current practice.
    Szklanny K; Jakubek M; Zbierska-Rubinkiewicz K; Undas A
    Adv Clin Exp Med; 2019 Apr; 28(4):469-477. PubMed ID: 30088350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
    Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
    BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.
    Siegal D; Yudin J; Kaatz S; Douketis JD; Lim W; Spyropoulos AC
    Circulation; 2012 Sep; 126(13):1630-9. PubMed ID: 22912386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.
    Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA
    Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
    Angelo M; Stockner I; Wiedermann CJ
    Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative management of patients with antiphospholipid syndrome: a single-center experience.
    Atisha-Fregoso Y; Espejo-Poox E; Carrillo-Maravilla E; Pulido-Ramírez AL; Lugo Baruqui D; Hernández-Molina G; Cabral AR
    Rheumatol Int; 2017 Jul; 37(7):1159-1164. PubMed ID: 28474094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Perioperative Management of Antithrombotic Therapies Using Enoxaparin.
    Hwang HG; Koo SM; Uh ST; Kim YK
    J Korean Med Sci; 2017 Jun; 32(6):942-947. PubMed ID: 28480651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does antiplatelet therapy affect outcomes of patients receiving abdominal laparoscopic surgery? Lessons from more than 1,000 laparoscopic operations in a single tertiary referral hospital.
    Fujikawa T; Tanaka A; Abe T; Yoshimoto Y; Tada S; Maekawa H; Shimoike N
    J Am Coll Surg; 2013 Dec; 217(6):1044-53. PubMed ID: 24051069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy.
    Klamroth R; Gottstein S; Essers E; Landgraf H
    Vasa; 2010 Aug; 39(3):243-8. PubMed ID: 20737383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative Management of Antiplatelets and Anticoagulants Among Patients Undergoing Elective Transurethral Resection of the Prostate--A Single Institution Experience.
    Ong WL; Koh TL; Fletcher J; Gruen R; Royce P
    J Endourol; 2015 Nov; 29(11):1321-7. PubMed ID: 26154769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.
    Spyropoulos AC; Al-Badri A; Sherwood MW; Douketis JD
    J Thromb Haemost; 2016 May; 14(5):875-85. PubMed ID: 26988871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of oral cavity bleeding and clinical outcome after dental procedures in patients on vitamin K antagonists. A cohort study.
    Biedermann JS; Rademacher WMH; Hazendonk HCAM; van Diermen DE; Leebeek FWG; Rozema FR; Kruip MJHA
    Thromb Haemost; 2017 Jun; 117(7):1432-1439. PubMed ID: 28405671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of periprocedural anticoagulant therapy: a novel individualized approach-a transeusophageal echocardiographic study.
    Durmaz E; Karadag B; İkitimur B; Ebren C; Tokdil H; Koca D; Ozmen E; Polat F; Ohtaroglu Tokdil K; Raimoglu U; Mutlu D; Atici A; Ongen Z
    J Thromb Thrombolysis; 2020 Aug; 50(2):408-415. PubMed ID: 32281070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
    Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S;
    Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
    Omran H; Hammerstingl C; Paar WD;
    Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.
    Cappato R; Marchlinski FE; Hohnloser SH; Naccarelli GV; Xiang J; Wilber DJ; Ma CS; Hess S; Wells DS; Juang G; Vijgen J; Hügl BJ; Balasubramaniam R; De Chillou C; Davies DW; Fields LE; Natale A;
    Eur Heart J; 2015 Jul; 36(28):1805-11. PubMed ID: 25975659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tincani E; Baldini P; Crowther MA; Zanasi A; Ferrari P; Cenci AM; Rioli G
    Blood Coagul Fibrinolysis; 2009 Jan; 20(1):47-51. PubMed ID: 20523164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.